Cavanal Hill Durable Equity (S:0P0001KCAU)
41.08
+0.37
(+0.90%)
USD |
Sep 30 2024
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
| Maximum Management Fee | Annualized Total Returns Since Inception (Daily) | Alpha (vs Category) (3Y) | Forecasted Dividend Yield |
|---|---|---|---|
| -- | -- | -- | -- |
| Total Market Value (Net) | Beta (vs Category) (3Y) | Max Drawdown (Since Inception) | Fwd Dividend Yield (Long) |
| Upgrade | Upgrade | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| Our investment process views stocks according to their fundamental financial traits for valuation, profitability, quality, momentum, and risk. We further analyze which traits have a higher degree of success in identifying stocks that will outperform in a given part of the business cycle. Further, the market environment and the general level of risk aversion can help to highlight potential opportunities. In concert with our assessment of the macroeconomic landscape, model results are then combined in order to create more stable expected returns and to diversify model dependence. |
| General | |
| Security Type | Separately Managed Account |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | |
| Peer Group | |
| Global Macro | |
| US Macro | |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Annual Total Returns Versus Peers
As of March 11, 2025.
*Indicates data for the year is incomplete.
Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | -- | -- | -- |
| Stock | -- | -- | -- |
| Bond | -- | -- | -- |
| Convertible | -- | -- | -- |
| Preferred | -- | -- | -- |
| Other | -- | -- | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Microsoft Corp | 7.76% | 380.22 | -3.33% |
| Apple Inc | 7.48% | 227.56 | -4.82% |
| Amazon.com Inc | 2.81% | 194.68 | -2.29% |
| Eli Lilly and Co | 2.78% | 829.00 | -4.67% |
| JPMorgan Chase & Co | 2.78% | 232.15 | -4.18% |
| UnitedHealth Group Inc | 2.76% | 480.35 | -2.66% |
| Visa Inc | 2.38% | 341.71 | -1.05% |
| Johnson & Johnson | 2.30% | 167.84 | 0.69% |
| NVIDIA Corp | 2.15% | 106.90 | -5.14% |
| Exxon Mobil Corp | 2.15% | 111.81 | 2.56% |
Fees & Availability
| Fees | |
| Negotiable Fee | No |
| Administrative Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Trustee Fee | -- |
| Purchase Details | |
| Open to New Investors | No |
| Minimum Initial Investment | -- |
| Minimum Subsequent Investment | -- |
Basic Info
| Investment Strategy | |
| Our investment process views stocks according to their fundamental financial traits for valuation, profitability, quality, momentum, and risk. We further analyze which traits have a higher degree of success in identifying stocks that will outperform in a given part of the business cycle. Further, the market environment and the general level of risk aversion can help to highlight potential opportunities. In concert with our assessment of the macroeconomic landscape, model results are then combined in order to create more stable expected returns and to diversify model dependence. |
| General | |
| Security Type | Separately Managed Account |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | |
| Peer Group | |
| Global Macro | |
| US Macro | |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fundamentals
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Forecasted Dividend Yield | -- |
| Forecasted PE Ratio | -- |
| Forecasted Price to Sales Ratio | -- |
| Forecasted Price to Book Ratio | -- |
Fund Details
| Key Dates | |
| Inception Date | 7/2/2012 |
| Last Annual Report Date | 12/31/2019 |
| Last Prospectus Date | 7/15/2020 |
| Attributes | |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |